Found 627 matching trials
Human Upper Extremity Allotransplantation PHASE2 Background: Millions of people each year sustain injuries, have tumors surg...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
Autologous Polyclonal Tregs for Lupus PHASE1 The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation PHASE1 This is a phase I single center dose escalation study with an extension at ...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies EARLY_PHASE1 Current treatments for relapsed/refractory hematopoietic malignancies such ...
Show More Location
Multiple Locations
Learn More & Join Trial
Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme PHASE1 Chimeric antigen receptor (CAR)-modified T cells can mediate long-term dura...
Show More Location
Sanbo Brain Hospital Capital Medical University
Learn More & Join Trial
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation PHASE1 The goal of this clinical research study is to learn if giving romidepsin b...
Show More Location
The Ohio State University Cancer Center
Learn More & Join Trial
Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome PHASE1 Background:
Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Se...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. PHASE2 RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Show More Location
Children's Memorial Hospital
Learn More & Join Trial
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies PHASE1 This Phase I dose-escalation trial is designed to evaluate the safety of ad...
Show More Location
Childrens National Medical Center
Learn More & Join Trial